Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Hilfinger

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Molecular Pharmaceutics|February 3, 2009
BCS in drug discovery, development, and regulationJohn M Hilfinger
Molecular Pharmaceutics|July 26, 2008
Enhanced cancer cell growth inhibition by dipeptide prodrugs of floxuridine: increased transporter affinity and metabolic stabilityYasuhiro Tsume, John M Hilfinger, Gordon L Amidon
Pharmaceutical Research|June 15, 2011
Potential of amino acid/dipeptide monoester prodrugs of floxuridine in facilitating enhanced delivery of active drug to interior sites of tumors: a two-tier monolayer in vitro studyYasuhiro Tsume, John M Hilfinger, Gordon L Amidon
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 24, 2013
The development of orally administrable gemcitabine prodrugs with D-enantiomer amino acids: enhanced membrane permeability and enzymatic stabilityYasuhiro Tsume, Tuba Incecayir, Xueqin Song, et al.
Molecular Pharmaceutics|January 24, 2013
Evolution of an amino acid based prodrug approach: stay tunedIvan S Krylov, Boris A Kashemirov, John M Hilfinger, et al.
Pharmaceutical Research|September 1, 2005
Floxuridine amino acid ester prodrugs: enhancing Caco-2 permeability and resistance to glycosidic bond metabolismChristopher P Landowski, Xueqin Song, Philip L Lorenzi, et al.
Molecular Pharmaceutics|February 6, 2007
Bile acid-oligopeptide conjugates interact with DNA and facilitate transfectionPhillip E Kish, Yasuhiro Tsume, Paul Kijek, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 15, 2007
Proline prodrug of melphalan, prophalan-L, demonstrates high therapeutic index in a murine melanoma modelSachin Mittal, Yasuhiro Tsume, Christopher P Landowski, et al.
Molecular Pharmaceutics|April 5, 2005
Amino acid ester prodrugs of the anticancer agent gemcitabine: synthesis, bioconversion, metabolic bioevasion, and hPEPT1-mediated transportXueqin Song, Philip L Lorenzi, Christopher P Landowski, et al.
Pharmaceutical Research|January 24, 2008
Pharmacokinetics of the CYP 3A substrate simvastatin following administration of delayed versus immediate release oral dosage formsMarija Tubic-Grozdanis, John M Hilfinger, Gordon L Amidon, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Molecular Pharmaceutics|February 3, 2009
BCS in drug discovery, development, and regulationJohn M Hilfinger
Molecular Pharmaceutics|July 26, 2008
Enhanced cancer cell growth inhibition by dipeptide prodrugs of floxuridine: increased transporter affinity and metabolic stabilityYasuhiro Tsume, John M Hilfinger, Gordon L Amidon
Pharmaceutical Research|June 15, 2011
Potential of amino acid/dipeptide monoester prodrugs of floxuridine in facilitating enhanced delivery of active drug to interior sites of tumors: a two-tier monolayer in vitro studyYasuhiro Tsume, John M Hilfinger, Gordon L Amidon
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 24, 2013
The development of orally administrable gemcitabine prodrugs with D-enantiomer amino acids: enhanced membrane permeability and enzymatic stabilityYasuhiro Tsume, Tuba Incecayir, Xueqin Song, et al.
Molecular Pharmaceutics|January 24, 2013
Evolution of an amino acid based prodrug approach: stay tunedIvan S Krylov, Boris A Kashemirov, John M Hilfinger, et al.
Pharmaceutical Research|September 1, 2005
Floxuridine amino acid ester prodrugs: enhancing Caco-2 permeability and resistance to glycosidic bond metabolismChristopher P Landowski, Xueqin Song, Philip L Lorenzi, et al.
Molecular Pharmaceutics|February 6, 2007
Bile acid-oligopeptide conjugates interact with DNA and facilitate transfectionPhillip E Kish, Yasuhiro Tsume, Paul Kijek, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 15, 2007
Proline prodrug of melphalan, prophalan-L, demonstrates high therapeutic index in a murine melanoma modelSachin Mittal, Yasuhiro Tsume, Christopher P Landowski, et al.
Molecular Pharmaceutics|April 5, 2005
Amino acid ester prodrugs of the anticancer agent gemcitabine: synthesis, bioconversion, metabolic bioevasion, and hPEPT1-mediated transportXueqin Song, Philip L Lorenzi, Christopher P Landowski, et al.
Pharmaceutical Research|January 24, 2008
Pharmacokinetics of the CYP 3A substrate simvastatin following administration of delayed versus immediate release oral dosage formsMarija Tubic-Grozdanis, John M Hilfinger, Gordon L Amidon, et al.
Pageof 2